Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Chinese Patent Office
Boehringer Ingelheim
Federal Trade Commission
Deloitte
Express Scripts
Queensland Health
US Army
Farmers Insurance

Generated: August 15, 2018

DrugPatentWatch Database Preview

SODIUM BUTABARBITAL Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Summary for SODIUM BUTABARBITAL
Drug patent expirations by year for SODIUM BUTABARBITAL

US Patents and Regulatory Information for SODIUM BUTABARBITAL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Pharms SODIUM BUTABARBITAL butabarbital sodium TABLET;ORAL 085418-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lannett SODIUM BUTABARBITAL butabarbital sodium TABLET;ORAL 085881-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ivax Sub Teva Pharms SODIUM BUTABARBITAL butabarbital sodium TABLET;ORAL 084040-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Marshall Pharma SODIUM BUTABARBITAL butabarbital sodium TABLET;ORAL 083524-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hikma Pharms SODIUM BUTABARBITAL butabarbital sodium TABLET;ORAL 085432-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ivax Sub Teva Pharms SODIUM BUTABARBITAL butabarbital sodium TABLET;ORAL 083484-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lannett SODIUM BUTABARBITAL butabarbital sodium TABLET;ORAL 085866-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Harvard Business School
Colorcon
Boehringer Ingelheim
Queensland Health
Dow
Johnson and Johnson
Fish and Richardson
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.